Biltmore Family Office, LLC Heron Therapeutics, Inc. Transaction History
Biltmore Family Office, LLC
- $572 Million
- Q4 2024
A detailed history of Biltmore Family Office, LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Biltmore Family Office, LLC holds 101,467 shares of HRTX stock, worth $175,537. This represents 0.03% of its overall portfolio holdings.
Number of Shares
101,467Holding current value
$175,537% of portfolio
0.03%Shares
3 transactions
Others Institutions Holding HRTX
# of Institutions
173Shares Held
114MCall Options Held
2MPut Options Held
32.4K-
Rubric Capital Management LP New York, NY26.7MShares$46.2 Million0.68% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.5MShares$14.7 Million0.02% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$14.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.16MShares$14.1 Million0.0% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$12.1 Million22.07% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $205M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...